Biblio Discovery — Demo Discovery Service

4 results for "Adam Cheifetz"

Showing 1–4 · 0.50 seconds · RSS

  1. Journal Article Full text

    Characterization of Human CD39 + Th17 Cells with Suppressor Activity and Modulation in Inflammatory Bowel Disease

    Maria Serena Longhi; Alan Moss; Aiping Bai et al.

    PLoS ONE, Vol. 9 No. 2 · 2014 · English · PLOS Scopus

    Induced regulatory T-cells (iT-reg) and T helper type 17 (Th17) in the mouse share common CD4 progenitor cells and exhibit overlapping phenotypic and functional features. Here, we show that human Th17 cells endowed with suppressor activity (supTh17) can be derived following exposure of iT-reg…

    Also available at: DOAJ

  2. Journal Article

    Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)

    Vipul Jairath; Guangyong Zou; Niels Vande Casteele et al.

    BMJ Open, Vol. 12 No. 4 · 2022 · English · DOAJ Scopus

    Introduction Preliminary data indicates that proactive therapeutic drug monitoring (TDM) is associated with better outcomes compared with empiric dose escalation and/or reactive TDM, and that pharmacokinetic (PK) modelling can improve the precision of individual dosing schedules in Crohn’s disease…

  3. Journal Article

    Clinical characteristics and treatment patterns of elderly versus non-elderly adults with inflammatory bowel disease in Brazil: a cross-sectional study

    Adam Cheifetz; Jaciane Araujo Mota; Genoile Oliveira Santana et al.

    BMJ Open Gastroenterology, Vol. 13 No. 1 · 2026 · English · DOAJ Scopus

    Objective Inflammatory bowel disease (IBD) is increasingly diagnosed in older adults, but data from Latin America remain limited. This study aimed to compare the clinical, phenotypic and therapeutic characteristics of elderly and non-elderly adults with IBD in Brazil.Methods This cross-sectional…